Search Results 611-620 of 18469 for Prednisone

  1. Understanding the Resistance to Enzalutamide in Patients with Castrate Resistant Metastatic Prostate Cancer - Mayo Clinic

    History of metastatic CRPC with clinical indication to start treatment with either abiraterone acetate/prednisone or enzalutamide. Exclusion Criteria: N/A ...

  2. Methotrexate (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is also used to treat rheumatoid arthritis, severe psoriasis (a skin disease), and polyarticular juvenile idiopathic arthritis (pJIA).

  3. Aspirin allergy: What are the symptoms? - Mayo Clinic

    If you have asthma, nasal polyps, chronic sinusitis or chronic hives (urticaria), you're more likely to have a reaction to aspirin or NSAIDs . When a reaction ...

  4. Tendinitis - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

    Subjects with a requirement for systemic steroids receiving >10 mg/day of prednisone (or equivalent) for the 2 weeks preceding start of study treatment.

  6. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    ... (prednisone or equivalent), and immunomodulators. Exclusion Criteria: * Participant has received any targeted therapies (TaTs) for UC, including but not ...

  7. Leflunomide (oral route) - Side effects & dosage - Mayo Clinic

    Leflunomide is used to treat active rheumatoid arthritis. This medicine works by stopping the body from producing too many of the immune cells that are ...

  8. A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis - Mayo Clinic

    Known history of allergy or reaction to any component of the mavrilimumab or placebo formulation or to any other biologic therapy or prednisone or any of its ...

  9. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    Participation eligibility · Requiring higher than physiologic steroid levels (> 10mg prednisone/day or equivalent) or · Requiring disease-modifying agents or.

  10. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis - Mayo Clinic

    Patient who are on prednisone therapy at a dose > 10 mg/day in the last 15 days. Patients who received rituximab previously with CD20 count of < 5 cells ...